Product Liability Defense Favored By Industry Appears To Have Supreme Court Support

US FDA's rejection of Merck's proposed Fosamax label warning preempts state-law tort suits, several Justices appear to conclude, as Kagan and Sotomayor question whether the proposal focused on the right risk.

Facade of US Supreme court in Washington DC on sunny day

The US Supreme Court seems likely to rule for Merck & Co. Inc. in a case addressing whether FDA rejection of a manufacturer's proposed label warning preempts state-law tort suits claiming the manufacturer failed to adequately warn of the product's risks.

During Jan. 7 oral argument in Merck Sharp & Dohme Corp. v. Albrecht, Chief Justice John Roberts Jr. and Justices...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Drug Safety

More from Pink Sheet